Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Safety and Efficacy Study of an Ex-vivo Antigen-primed Donor Memory Lymphocyte Infusion for the Enhancement of Immunity to Viral Infections Among Recipients of Allogeneic Hematopoietic Stem Cell Transplantation on the Platform of Selective Immunomagnetic Depletion of T-lymphocytes

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05066958
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:28.454781+00:00
Published At
2021-10-04T00:00:00+00:00
Record Updated At
2021-10-04
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Acute Myeloid Leukemia", "High Risk Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia, in Relapse", "High Risk Acute Lymphoblastic Leukemia", "Acute Biphenotypic Leukemia in Relapse", "Non-hodgkin Lymphoma", "Myelodysplastic Syndromes"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-10-04"
protocolSection.identificationModule.nctId
"NCT05066958"
protocolSection.identificationModule.officialTitle
"Safety and Efficacy Study of an Ex-vivo Antigen-primed Donor Memory Lymphocyte Infusion for the Enhancement of Immunity to Viral Infections Among Recipients of Allogeneic Hematopoietic Stem Cell Transplantation on the Platform of Selective Immunomagnetic Depletion of T-lymphocytes"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • High Risk Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Acute Lymphoblastic Leukemia, in Relapse (protocolSection.conditionsModule.conditions)
  • High Risk Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Acute Biphenotypic Leukemia in Relapse (protocolSection.conditionsModule.conditions)
  • Non-hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.